A Communication Strategy for Families of Patients Dying in the ICU

Family of Dying Patient in the ICU Clinical Trial

Official title:

A Proactive Communication Strategy for Family Members of Patients Dying in the ICU: A Multicenter Randomized Controlled Trial

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT00331877
• Other study ID #: famirea VIII
• Status: Terminated
• Phase: N/A
• First received: May 30, 2006
• Last updated: May 30, 2006
• Start date: May 2005
• Est. completion date: January 2006

Study information

• Verified date: May 2006
• Source: Famirea Study Group
• Contact: n/a
• Is FDA regulated: No
• Health authority: France: Assistance publique hopitaux de Paris
• Study type: Interventional

Clinical Trial Summary

Decisions to limit life sustaining treatments are made for most patients dying in the ICU, usually with input from the family. The well-being of the family may be jeopardized by involvement in the decision-making process and bereavement. We evaluated the ability of a proactive communication strategy (family conference and providing family members with a bereavement information leaflet) designed to improve family well-being.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 136
• Est. completion date: January 2006
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• family of dying patient

Exclusion Criteria:

• family having no enough knowledge of French to respond to telephone interview

• patient alive on day 90

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double-Blind, Primary Purpose: Educational/Counseling/Training

Related Conditions & MeSH terms

• Family of Dying Patient in the ICU

Intervention

Procedure:
• family conference with bereavement information leaflet

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Famirea Study Group

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	symptoms related to posttraumatic stress disorder
Secondary	symptoms of anxiety and depression